Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results von Esin, E., Cakmak Oksuzoglu, O.B., Bilici, A., Cicin, I., Aksoy, S., Alacacioglu, A., Kaplan, M.A., Cabuk, D., Sumbul, A.T., Paydas, S., Sakin, A., Er, Ö, Korkmaz, T., Yildirim, N., Artac, M., Harputluoglu, H., Yumuk, P.F., Basaran, G., Oyan Uluc, B., Demirci, U.

Volltext

Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience von Aksoy, S., Dizdar, O., Harputluoglu, H., Altundag, K.

Volltext

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes von Esin, Ece, Oksuzoglu, B., Bilici, A., Cicin, I., Kostek, O., Kaplan, M. A., Aksoy, S., Aktas, B. Y., Ozdemir, O., Alacacioglu, A., Cabuk, D., Sumbul, A. T., Sakin, A., Paydas, S., Yetisir, E., Er, O., Korkmaz, T., Yildirim, N., Sakalar, T., Demir, H., Artac, M., Karaagac, M., Harputluoglu, H., Bilen, E., Erdur, E., Degirmencioglu, S., Aliyev, A., Cil, T., Olgun, P., Basaran, G., Gumusay, O., Demir, A., Tanrikulu, E., Yumuk, P. F., Imamoglu, Inanc, Oyan, B., Cetin, B., Haksoyler, V., Karadurmus, N., Erturk, I., Evrensel, T., Yilmaz, H., Beypinar, I., Kocer, M., Pilanci, K. N., Seker, M., Urun, Y., Yildirim, N., Eren, T., Demirci, U.

Volltext

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study von Harbeck, N., Rastogi, P., Martin, M., Tolaney, S.M., Shao, Z.M., Fasching, P.A., Huang, C.S., Jaliffe, G.G., Tryakin, A., Goetz, M.P., Rugo, H.S., Senkus, E., Testa, L., Andersson, M., Tamura, K., Del Mastro, L., Steger, G.G., Kreipe, H., Hegg, R., Sohn, J., Guarneri, V., Cortés, J., Hamilton, E., André, V., Wei, R., Barriga, S., Sherwood, S., Forrester, T., Munoz, M., Shahir, A., San Antonio, B., Nabinger, S.C., Toi, M., Johnston, S.R.D., O’Shaughnessy, J., Jimenez, M.M., Johnston, S., Boyle, F., Steger, G.G., Neven, P., Jiang, Z., Campone, M., Huober, J., Shimizu, C., Cicin, I., Wardley, A., Tolaney, S.M., Abuin, G.G., Zarba, J., Lim, E., Sant, P., Liao, N., Christiansen, B., Eigeliene, N., Martin-Babau, J., Ettl, J., Mavroudis, D., Chiu, J., Boer, K., Nagarkar, R., Paluch-Shimon, S., Moscetti, L., Sagara, Y., Kim, S.-B., Maciel, M.M., Tjan-Heijnen, V., Broom, R., Lacko, A., Schenker, M., Volkov, N., Sim Yap, Y., Coccia-Portugal, M., Ángel García Sáenz, J., Andersson, A., Chao, T.-Y., Gokmen, E., Harputluoglu, H., Berzoy, O., Patt, D., McArthur, H., Chew, H., Chalasani, P., Kaufman, P., Tedesco, K., Graff, S.L.

Volltext

How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2? von Harputluoglu, H., Altundag, K.

Volltext

Erectile dysfunction in testicular cancer patients treated with chemotherapy von Tasdemir, C., Firdolas, F., Harputluoglu, H., Altintas, R., Gunes, A.

Volltext

Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors von AKSOY, S., KILICKAP, S., HAYRAN, M., HARPUTLUOGLU, H., KOCA, E., DEDE, D. S., ERMAN, M., TURKER, A.

Volltext

1206MO ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK+ non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo) von Solomon, B.J., Wu, Y-L., Dziadziuszko, R., Barlesi, F., Nishio, M., Ahn, J.S., Horinouchi, H., Hochmair, M.J., de Marinis, F., Migliorino, M.R., Kurochkin, A., Harputluoglu, H., Planchard, D., Korphaisarn, K., Han, J-Y., Lohmann, T., Cardona Gavaldon, A., Archer, V.R., Nowicka, M., Noe, J.

Volltext

1261TiP CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal juncti... von Esposito, F.M., Lee, J., Rha, S.Y., Penkov, K.D., Moisseev, A., Van Den Eynde, M., Prenen, H., Díez García, M., Gumus, M., Sagawa, T., Nechaeva, M., Kajiwara, T., Harputluoglu, H., Charbonnier, L., Bensfia, S., Yang, N., Oh, D-Y.

Volltext

P-92 Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turk... von Artac, M., Cubukcu, E., Bozkurt, O., Bilici, A., Celik, S., Ozcelik, M., Oven, B., Simsek, E., Geredeli, C., Karaca, M., Cil, T., Harputluoglu, H., Şendur, M., Turk, H., Kefeli, U., Alacacioglu, A., Tural, D., Sakin, A., Karadurmus, N., Çevik, D., Dane, F., Gumus, M.

Volltext

P-90 First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis von Isıkdogan, A., Turk, H., Bilir, C., Şendur, M., Karabulut, B., Artac, M., Cicin, I., Geredeli, C., Alacacioglu, A., Kefeli, U., Harputluoglu, H., Bozkurt, O., Cubukcu, E., Tural, D., Sakin, A., Cil, T., Dane, F., Çevik, D., Arslan, Ç., Karadurmus, N., Gumus, M., Yalcin, S.

Volltext

P-219 Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study von Ç. Arslan, Kefeli, U., Yildirim, E., Isıkdogan, A., Karadurmus, N., Karabulut, B., Cicin, I., Cubukcu, E., Bilir, C., Ozcelik, M., Cil, T., Celik, S., Bozkurt, O., Harputluoglu, H., Oven, B., Geredeli, C., Tural, D., Sakin, A., Çevik, D., Gumus, M., Yalcin, S.

Volltext

LBA2 First-line (1L) durvalumab (D) + platinum-etoposide (EP) for patients (pts) with extensive-stage SCLC (ES-SCLC): Primary results from the phase IIIb LUMINANCE study von Reinmuth, N., Özgüroğlu, M., Leighl, N.B., Galetta, D., Hacibekiroglu, I., Roubec, J., Sendur, M.A.N., Bria, E., Cicin, I., Grohé, C., Harputluoglu, H., Kilickap, S., Novello, S., Opalka, P., Riccardi, F., Ruseva, R.K., Lang, S., Hodari, M., Donner, N., de Marinis, F.

Volltext

Abstract P3-01-21: Is lymph node ratio (LNR) having additional contribution for predict prognosis on pathologic lymph node staging in node-positive breast cancer patients? von Kaplan, MA, Odabasi, H, Ozdemir, N, Harputluoglu, H, Aliustaoglu, M, Berk, V, Gunaydin, Y, Uncu, D, Elkiran, T, Aydin, D, Isikdogan, A

Volltext

325PPertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: Real life practice results von Esin, E, Cakmak Oksuzoglu, O B, Bilici, A, Cicin, I, Aksoy, S, Alacacioglu, A, Kaplan, M A, Cabuk, D, Sumbul, A T, Paydas, S, Sakin, A, Er, Ö, Korkmaz, T, Yildirim, N, Artac, M, Harputluoglu, H, Yumuk, P F, Basaran, G, Oyan Uluc, B, Demirci, U

Volltext

Differential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients von ELKIRAN, T, HARPUTLUOGLU, H, YASAR, U, BABAOGLU, M. O, DINCEL, A. K, ALTUNDAG, K, OZISIK, Y, GULER, N, BOZKURT, A

Volltext

Zoledronic acid and atrial fibrillation in cancer patients with bone metastases von Aksoy, S., Dizdar, Ö., Turgut, D., Sener Dede, D., Arslan, Ç., Harputluoglu, H., Altundag, K.

Volltext

Predictive factors for metastasis in patients (pts) with gastric cancer von Kilickap, S., Dizdar, O., Harputluoglu, H., Aksoy, S., Yalcin, S.

Volltext

Medical Plants Oils and Extracts Are an Antiproliferative Agent for Cancer Cells von Harputluoglu, H., Taştekin, D.

Volltext

Metastatic granular cell tumor: A case report and review of the literature von Aksoy, Sercan, Abali, Huseyin, Kilickap, Saadettin, Harputluoglu, Hakan, Erman, Mustafa

Volltext